Industry funding biases drug trial studies in favor of sponsors' products

February 21, 2017, University of Sydney

The review, which adds 27 studies to update a previous Cochrane review, confirms earlier analyses by "providing definitive evidence that pharmaceutical industry funding of drug studies biases the results and conclusions to look favourable towards the drug of the sponsor," said senior author, Professor Lisa Bero of the University of Sydney's Charles Perkins Centre.

The authors note there are several potential ways that sponsors can influence the outcome of a study, including the framing of questions, the design of a study, the conduct of a study, how data are analysed, selective reporting of favourable results, and "spin" in reporting .

Also, while some journals now require that the role of the sponsor in the design, conduct and publication of the study be described, this practice is not widespread.

Professor Bero said the key concern associated with industry-sponsored research evaluating drugs and medical devices was that there were no standard tools or validated criteria that include industry sponsorship as a risk of bias for such studies.

"We need bias assessments tools for drug studies that take funding source into account," Professor Bero said. "Currently, we have no validated way to detect or evaluate these subtle but systematic biases."

Key findings

Compared to non-industry sponsored studies, industry sponsored and medical device studies:

  • More often had efficacy results that were more favourable to the sponsor's product (relative risk 1.27, confidence interval 1.19-1.37)
  • More often had favourable overall conclusions (relative risk 1.34, confidence interval 1.19-1.51)
  • Had less agreement between stated results and overall conclusions (relative risk 0.83, confidence interval 0.70-0.98).

Co-author to the review, Dr Joel Lexchin, Professor Emeritus of York University, said the findings were especially concerning for patients and doctors.

"Our views about the effectiveness and safety of many medicines may be distorted. Medicines may be both less safe and less effective than we think to the extent that the evidence about them comes from the companies making them," he said.

Explore further: Analysis of reports quantitatively comparing food-industry sponsored studies

Related Stories

Analysis of reports quantitatively comparing food-industry sponsored studies

October 31, 2016
Researchers in Australia analyzed medical literature to determine whether nutrition studies sponsored by the food industry were associated with outcomes favorable to the sponsor.

Industry sponsorship leads to bias in reported findings of clinical trials

December 11, 2012
Studies reporting the results of industry sponsored clinical trials present a more favourable picture of the effects of drugs and medical devices than those reporting on non-industry sponsored trials, according to a new Cochrane ...

Artificial sweeteners hit sour note with sketchy science

September 26, 2016
University of Sydney researchers have confirmed widespread bias in industry-funded research into artificial sweeteners, which is potentially misleading millions by overstating their health benefits.

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

Commercial interests may drown out patients' voices

January 17, 2017
Researchers from the University of Sydney and Bond University are urgently calling for greater independence and transparency around industry-sponsored patient advocacy groups, following a growing amount of evidence which ...

Design flaws plague many animal-based drug studies, researchers say

January 22, 2014
(HealthDay)—Many pharmaceutical studies in animals that lead to trials in humans have serious design flaws, a new study suggests.

Recommended for you

Calcium and Vitamin D supplements are not associated with risk of heart attacks

February 16, 2018
New research from the University of Southampton has found no association between the use of calcium or vitamin D supplementation and cardiovascular events such as heart attacks.

Study shows options to decrease risk of motor vehicle crashes for adolescent drivers

February 16, 2018
Adolescents who receive comprehensive and challenging on-road driving assessments prior to taking the license test might be protected from future motor vehicle crashes, according to a University of Alabama at Birmingham study ...

Being a single dad can shorten your life: study

February 15, 2018
The risk of dying prematurely more than doubles for single fathers compared to single mothers or paired-up dads, according to a study of Canadian families published Thursday.

Keeping an eye on the entire ageing process

February 15, 2018
Medical researchers often only focus on a single disease. As older people often suffer from multiple diseases at the same time, however, we need to rethink this approach, writes Ralph Müller.

Study suggests possible link between highly processed foods and cancer

February 14, 2018
A study published by The BMJ today reports a possible association between intake of highly processed ("ultra-processed") food in the diet and cancer.

Gov't says health costs to keep growing faster than economy

February 14, 2018
U.S. health care spending will keep growing faster than the overall economy in the foreseeable future, squeezing public insurance programs and employers who provide coverage, the government said Wednesday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.